The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
Open accessAbstract
The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citationThe human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Self-citationAssociation of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citationT antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Cited by
Sorted by citations
Items 201–300 of 879
Bul1, a New Protein That Binds to the Rsp5 Ubiquitin Ligase in Saccharomyces cerevisiae
Yashiroda, H., Oguchi, T., Yasuda, Y. U., Toh‐e, A., & Kikuchi, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3255 · Cited by 104
p53 polymorphism in human papillomavirus-associated esophageal cancer.
Kawaguchi, H., Ohno, S., Araki, K., Miyazaki, M., Saeki, H., Watanabe, M., Tanaka, S., & Sugimachi, K. (2000) · PubMed · Cited by 103
Identification of an α Helical Motif Sufficient for Association with Papillomavirus E6
Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J., & Androphy, E. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13537 · Cited by 99
Ciechanover, A. J., Shkedy, D., Oren, M., & Bercovich, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36921-1 · Cited by 99
Pim, D., Thomas, M., Javier, R., Gardiol, D., & Banks, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203374 · Cited by 99
Identification and Proteomic Analysis of Distinct UBE3A/E6AP Protein Complexes
Martínez-Noël, G., Galligan, J. T., Sowa, M. E., Arndt, V., Overton, T. M., Harper, J. W., & Howley, P. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00201-12 · Cited by 102
Self-citationBAF60a Interacts with p53 to Recruit the SWI/SNF Complex
Oh, J., Sohn, D. H., Ko, M., Chung, H., Jeon, S. H., & Seong, R. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705401200 · Cited by 97
E6AP promotes the degradation of the PML tumor suppressor
Louria‐Hayon, I., Alsheich-Bartok, O., Levav-Cohen, Y., Silberman, I., Berger, M., Grossman, T., Matentzoglu, K., Jiang, Y.-H., Müller, S. P., Scheffner, M., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.31 · Cited by 96
Self-citationRole of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96
Dell, G., & Gaston, K. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000827 · Cited by 96
Characterization of the DOC1/APC10 Subunit of the Yeast and the Human Anaphase-promoting Complex
Grossberger, R., Gieffers, C., Zachariae, W., Podtelejnikov, A. V., Schleiffer, A., Nasmyth, K., Mann, M., & Peters, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14500 · Cited by 96
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network
Eckhardt, M., Zhang, W., Gross, A. M., Dollen, J. V., Johnson, J. R., Franks-Skiba, K. E., Swaney, D. L., Johnson, T. L., Jang, G. Μ., Shah, P. S., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1018 · Cited by 97
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
Garnett, T. O., & Duerksen-Hughes, P. J. (2006) · Archives of Virology · doi:10.1007/s00705-006-0821-0 · Cited by 95
Mésplède, T., Gagnon, D., Bergeron-Labrecque, F., Azar, I. H., Sénéchal, H., Coutlée, F., & Archambault, J. (2011) · Journal of Virology · doi:10.1128/jvi.00751-11 · Cited by 102
Strati, K., & Lambert, P. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3007 · Cited by 96
Angelman syndrome: how many genes to remain silent?
Rougeulle, C., & Lalande, M. (1998) · Neurogenetics · doi:10.1007/s100480050034 · Cited by 94
Beta-HPV 5 and 8 E6 Promote p300 Degradation by Blocking AKT/p300 Association
Howie, H. L., Koop, J. I., Weese, J., Robinson, K. L., Wipf, G. C., Kim, L., & Galloway, D. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002211 · Cited by 97
Ubiquitin-dependent protein degradation: a cellular perspective
Jentsch, S. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90013-d · Cited by 91
Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes
Álvarez-Salas, L. M., Cullinan, A. E., Siwkowski, A. M., HAMPEL, A. E., & DiPaolo, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1189 · Cited by 94
Ubiquitin, E6-AP, and Their Role in p53 Inactivation
Scheffner, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00003-5 · Cited by 93
Self-citationHong, S., & Laimins, L. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003295 · Cited by 93
Kiernan, R. E., Emiliani, S., Nakayama, K., Castro, A., Labbé, J. C., Lorca, T., Nakayama, K., & Benkirane, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.7956-7970.2001 · Cited by 93
Human papillomaviruses and the specificity of PDZ domain targeting
Pim, D., Bergant, M., Boon, S. S., Ganti, K., Kranjec, C., Massimi, P., Subbaiah, V. K., Thomas, M., Tomaić, V., & Banks, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08709.x · Cited by 97
Khatri, N., & Man, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00109 · Cited by 96
Ubiquitin and the Enigma of Intracellular Protein Degradation
Jennissen, H. P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20665.x · Cited by 92
Patel, D., Incassati, A., Wang, N., & McCance, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2917 · Cited by 91
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway
Wallace, N. A., Khanal, S., Robinson, K. L., Wendel, S. O., Messer, J. J., & Galloway, D. A. (2017) · Journal of Virology · doi:10.1128/jvi.01084-17 · Cited by 94
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6
Pim, D., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203134 · Cited by 90
Zwerschke, W., & Jansen‐Dürr, P. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)61022-2 · Cited by 92
The papillomavirus E6 proteins
Rapp, L., & Chen, J. J. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00009-2 · Cited by 89
Cherry, J. J., Rietz, A., Malinkevich, A., Liu, Y., Xie, M., Bartolowits, M. D., Davisson, V. J., Baleja, J., & Androphy, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084506 · Cited by 97
Boulenouar, S., Weyn, C., Noppen, M. V., Ali, M. M., Fãvre, M., Delvenne, P., Bex, F., Noël, A., Englert, Y., & Fontaine, V. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp281 · Cited by 89
Dalal, S., Gao, Q., Androphy, E. J., & Band, V. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.683-688.1996 · Cited by 89
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 89
p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis
Chiou, S., & White, E. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3515-3525.1997 · Cited by 88
STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle
Morgan, E. L., Wasson, C. W., Hanson, L., Kealy, D., Pentland, I., McGuire, V. A., Scarpini, C. G., Coleman, N., Arthur, J. S. C., Parish, J. L., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006975 · Cited by 89
Genome guardian p53 and viral infections
Sato, Y., & Tsurumi, T. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1738 · Cited by 90
Cooper, B., Schneider, S., Bohl, J., Jiang, Y.-H., Beaudet, A. L., & Pol, S. V. (2003) · Virology · doi:10.1016/s0042-6822(02)00012-0 · Cited by 86
Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4
Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., & Sakai, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10914-10920.2002 · Cited by 87
Srivenugopal, K. S., & Ali‐Osman, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205762 · Cited by 87
Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein
Regan, J. A., & Laimins, L. A. (2008) · Journal of Virology · doi:10.1128/jvi.01240-08 · Cited by 85
Emerging Themes in PDZ Domain Signaling
Liu, X., & Fuentes, E. J. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.013 · Cited by 86
Who’s in charge? Nuclear receptor coactivator and corepressor function in brain and behavior
Tetel, M. J., Auger, A. P., & Charlier, T. D. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.008 · Cited by 86
Human Papillomaviruses and Skin Cancer
Smola, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_10 · Cited by 85
Khan, O. Y., Fu, G., Ismail, A., Srinivasan, S., Cao, X., Tu, Y., Lu, S., & Nawaz, Z. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0110 · Cited by 82
Elbel, M., Carl, S., Spaderna, S., & Iftner, T. (1997) · Virology · doi:10.1006/viro.1997.8860 · Cited by 82
Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53.
Yap, N., Yu, C., & Cheng, S.-Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4273 · Cited by 82
Xie, X., Piao, L., Bullock, B. N., Smith, A., Su, T., Zhang, M., Teknos, T. N., Arora, P. S., & Pan, Q. (2013) · Oncogene · doi:10.1038/onc.2013.25 · Cited by 80
Gao, Q., Singh, L., Kumar, A., Srinivasan, S. V., Wazer, D. E., & Band, V. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4459-4466.2001 · Cited by 81
Clemente-Soto, A. F., Vidal, E. S., Millán‐Pacheco, C., Sánchez‐Carranza, J. N., Peralta-Zaragoza, Ó., & lez‐Maya, L. G. ⁄. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9850 · Cited by 80
Katzenellenbogen, R. A., Egelkrout, E. M., Vliet-Gregg, P. A., Gewin, L. C., Gafken, P. R., & Galloway, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.02007-06 · Cited by 80
Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma
Borozan, I., Zapatka, M., Frappier, L., & Ferretti, V. (2017) · Journal of Virology · doi:10.1128/jvi.01239-17 · Cited by 80
Smith, C. S., DeVera, D. G., Lamb, D. J., Nawaz, Z., Jiang, Y., Beaudet, A. L., & O’Malley, B. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.525-535.2002 · Cited by 80
Kim, Y., Thomas, N. F., Kessis, T. D., Wilkinson, E. J., Hedrick, L., & Cho, K. R. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90113-6 · Cited by 80
The Role of Inflammation in Cervical Cancer
Sankaran, D., Marzook, K. H., & Pillai, M. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_15 · Cited by 79
Kuo, C.-L., & Goldberg, A. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701734114 · Cited by 78
Mandel‐Brehm, C., Salogiannis, J., Dhamne, S. C., Rotenberg, A., & Greenberg, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504809112 · Cited by 77
Miller, D. L., Puricelli, M. D., & Stack, M. S. (2012) · Biochemical Journal · doi:10.1042/bj20112017 · Cited by 76
Ubiquitin and Ubiquitin-Like Modifications of the p53 Family
Watson, I. R., & Irwin, M. S. (2006) · Neoplasia · doi:10.1593/neo.06439 · Cited by 77
Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins
Schweiger, M. R., Ottinger, M., You, J., & Howley, P. M. (2007) · Journal of Virology · doi:10.1128/jvi.00447-07 · Cited by 76
Self-citationLu, Y., Wang, F., Li, Y., Ferris, J., Lee, J., & Gao, F. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn373 · Cited by 76
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
Griffin, H. M., Elston, R., Jackson, D. J., Ansell, K. H., Coleman, M. M., Winter, G. P., & Doorbar, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.077 · Cited by 76
Cellular transformation by papilomavirus oncorproteins
Mansur, C. P. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90013-3 · Cited by 76
An alternative approach to monitoring cancer patient survival
Brenner, H., & Gefeller, O. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961101)78:9 · Cited by 365
Human papillomavirus and cervical carcinogenesis
Stanley, M. (2001) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2001.0213 · Cited by 72
Sherman, L., Jackman, A., Itzhaki, H., Stoppler, M. C., Koval, D., & Schlegel, R. (1997) · Virology · doi:10.1006/viro.1997.8778 · Cited by 73
Baleja, J., Cherry, J. J., Liu, Z., Gao, H., Nicklaus, M. C., Voigt, J. H., Chen, J. J., & Androphy, E. J. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.014 · Cited by 71
Aberrant ubiquitin-mediatedproteolysis of cell cycle regulatory proteins and oncogenesis
Bashir, T., & Pagano, M. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88305-7 · Cited by 73
Beeck, A. O. D., & Caillet-Fauquet, P. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_1 · Cited by 73
Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein
Brimer, N., Lyons, C. E., & Pol, S. V. (2006) · Virology · doi:10.1016/j.virol.2006.08.038 · Cited by 71
Jabbar, S. F., Strati, K., Shin, M. K., Pitot, H. C., & Lambert, P. F. (2010) · Virology · doi:10.1016/j.virol.2010.08.003 · Cited by 72
The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer
Ronchi, V. P., Klein, J. M., Edwards, D. J., & Haas, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517805 · Cited by 70
Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain
Chan, W. M., Mak, M. C., Fung, T. K., Lau, A. W. S., Siu, W. Y., & Poon, R. Y. C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0097 · Cited by 70
Epigenetic Regulation of the Human Papillomavirus Life Cycle
Mac, M., & Moody, C. A. (2020) · Pathogens · doi:10.3390/pathogens9060483 · Cited by 75
p53 Superfamily Proteins in Marine Bivalve Cancer and Stress Biology
Walker, C. W., Beneden, R. J. V., Muttray, A. F., Böttger, S. A., Kelley, M. L., Tucker, A. E., & Thomas, W. K. (2011) · Advances in marine biology · doi:10.1016/b978-0-12-385536-7.00001-7 · Cited by 72
The Structure, Function, and Regulation of Papillomaviral Genes in Infection and Cervical Cancer
Turek, L. P. (1994) · Advances in virus research · doi:10.1016/s0065-3527(08)60332-2 · Cited by 71
Proteomic approaches to the study of papillomavirus–host interactions
White, E. A., & Howley, P. M. (2012) · Virology · doi:10.1016/j.virol.2012.09.046 · Cited by 71
Self-citationRuttkay-Nedecký, B., Jimenez, A. M. J., Nejdl, L., Chudobová, D., Gumulec, J., Masařík, M., Adam, V., & Kizek, R. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2105 · Cited by 70
Modulation of the DNA damage response during the life cycle of human papillomaviruses
Anacker, D. C., & Moody, C. A. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.006 · Cited by 70
Transcriptional responses of host peripheral blood cells to tuberculosis infection
Lesho, E. P., Forestiero, F., Hirata, M. H., Hirata, R. D. C., Cecon, L., de Melo, F. A. F., Paik, S. H., Murata, Y., Ferguson, E. W., Wang, Z., et al. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.07.002 · Cited by 68
Murashima, S., Kumashiro, R., Ide, T., Miyajima, I., Hino, T., Koga, Y., Ishii, K., Ueno, T., Sakisaka, S., & Sata, M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200010)62:2 · Cited by 22
Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao, Q., Kumar, A., Singh, L., Huibregtse, J. M., Beaudenon, S. L., Srinivasan, S. V., Wazer, D. E., Band, H., & Band, V. (2002) · PubMed · Cited by 69
Self-citationHuman tumor suppressor p53 and DNA viruses
Collot-Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 69
p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer
Summersgill, K. F., Smith, E., Kirchner, H. L., Haugen, T. H., & Turek, L. P. (2000) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1067/moe.2000.107359 · Cited by 67
Richard, C., Lannér, C., Naryzhny, S., Sherman, L., Lee, H., Lambert, P. F., & Zehbe, I. (2010) · Oncogene · doi:10.1038/onc.2010.93 · Cited by 66
Wallace, N. A., & Galloway, D. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.003 · Cited by 68
E3 ubiquitin ligase E6AP‐mediated TSC2 turnover in the presence and absence of HPV16 E6
Li, Z., Ding, H., Lu, Z., Li, Y., Pan, Y., Ning, T., & Yang, K. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01162.x · Cited by 69
Elston, R. C., Doorbar, J., & Napthine, S. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-2-371 · Cited by 66
Manipulation of the ubiquitin–proteasome pathway by small DNA tumor viruses
Blanchette, P., & Branton, P. E. (2008) · Virology · doi:10.1016/j.virol.2008.10.005 · Cited by 64
Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways
Wimmer, P., & Schreiner, S. (2015) · Viruses · doi:10.3390/v7092849 · Cited by 66
Ganti, K., Massimi, P., Manzo-Merino, J., Tomaić, V., Pim, D., Playford, M. P., Lizano, M., Roberts, S., Kranjec, C., Doorbar, J., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005854 · Cited by 69
Tristetraprolin: Roles in cancer and senescence
Ross, C. R., Brennan-Laun, S. E., & Wilson, G. M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.005 · Cited by 66
Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G. P., Wazer, D. E., Band, H., & Band, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208447200 · Cited by 64
Describing the Silent Human Virome with an Emphasis on Giant Viruses
Popgeorgiev, N., Temmam, S., Raoult, D., & Desnues, C. (2013) · Intervirology · doi:10.1159/000354561 · Cited by 62
Andoh, T., Hirata, Y., & Kikuchi, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6712-6720.2000 · Cited by 62
Viruses – seeking and destroying the tumor program
O’Shea, C. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209047 · Cited by 65
Novel Functions of the Human Papillomavirus E6 Oncoproteins
Wallace, N. A., & Galloway, D. A. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055021 · Cited by 70
Wang, H., Mo, P., Ren, S., & Yan, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058669 · Cited by 64
Shamanna, R. A., Hoque, M., Pe’ery, T., & Mathews, M. B. (2012) · Oncogene · doi:10.1038/onc.2012.533 · Cited by 64
Anti-human papillomavirus therapeutics: facts & future.
Bharti, A. C., Shukla, S., Mahata, S., Hedau, S. T., & Das, B. C. (2009) · PubMed · Cited by 63
Metadata
- Authors
- Huibregtse, J. M., Scheffner, M., & Howley, P. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- The EMBO Journal
- Published
- 1991-12-01
- Volume
- 10
- Issue
- 13
- Pages
- 4129-4135
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC453163
- OpenAlex
- W140061535
- Cited by
- 879
- References
- 46
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 16 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 27 · 2019: 18 · 2018: 28 · 2017: 29 · 2016: 19 · 2015: 26 · 2014: 29 · 2013: 28 · 2012: 41
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p53, E6 oncoprotein, HPV16, HPV 18, UBE3A, ubiquitin-mediated proteolysis, p53 degradation, protein-protein interaction, keratinocytes, tumor suppressor
- MeSH terms
- Animals, Cell Line, Chromatography, Gel, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Humans, Hydrolysis, Oncogene Proteins, Viral, Plasmids, Protein Binding, Proteins, Repressor Proteins, Reticulocytes, Tumor Suppressor Protein p53, Papillomaviridae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review